Design, synthesis and antitumor evaluation of ATP dual-mimic 2,4-diarylaminopyrimidine and aminoindazole conjugates as potent anaplastic lymphoma kinase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, synthesis and antitumor evaluation of ATP dual-mimic 2,4-diarylaminopyrimidine and aminoindazole conjugates as potent anaplastic lymphoma kinase inhibitors

Published:2022-11 Issue: Volume:241 Page:114626
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Yang Jing,Ma Deyi,Liu Shuyu,Tan Zehui,Guo Ming,Cao Zhi,Zhang Jiahao,Zhai Xin^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference29 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. EML4-ALK variants: biological and molecular properties, and the implications for patients;Sabir;Cancers,2017

3. Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial;Mansfield;npj Precis. Onc.,2022

4. Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma;Takeuchi;Haematologica,2011

5. Drug discovery targeting anaplastic lymphoma kinase (ALK);Kong;J. Med. Chem.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of highly potent 2,4‐diarylaminopyrimidine analogs of a typical piperidinyl‐4‐ol moiety as promising antitumor ALK inhibitors;Archiv der Pharmazie;2023-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP